Decision

Advertising investigations: December 2017

Decisions made by MHRA following investigations into complaints about advertising for licensed medicines.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 22 February 2018

Documents

18 December 2017: Nelsons Homeopathic Pharmacy

HTML

December 2017: Overseas Conferences Organised by UK Wholesalers in 2017

HTML

December 2017: Conduct of Kyowa Kirin Representatives at Meeting

HTML

December 2017: Promotion of Monofer Solution for injection & infusion (Iron Isomaltoside) by Pharmacosmos Representative

HTML

December 2017: Fontus Saver Website for healthcare professionals

HTML

November-December 2017 - Clinics advertising botulinum toxin products

HTML

Details

Contact advertising@mhra.gov.uk if you have concerns with the advertising of medicines or write to:

Advertising Standards Unit,
151 Buckingham Palace Road
Victoria
London SW1W 9SZ

Alternatively, contact the pharmaceutical self-regulatory bodies, the Proprietary Association of Great Britain (PAGB) for advertising for over the counter medicines, or the Prescription Medicines Code of Practice Authority (PMCPA) for advertisements to health professionals for prescription medicines.

See the Blue Guide for guidance on how medicines should be promoted or advertised in the UK.

Published 22 February 2018